NSE filing, NSE: ANTELOPUS. Summary written from the filing by ALFA Finder's alert engine.
Antelopus Selan Energy Ltd: key numbers
- Share price
- ₹1,055.30
- Market cap
- ₹3,729 Cr
- Revenue (annual)
- ₹278.9 Cr
- Net profit (annual)
- ₹89.61 Cr
- P/E (TTM)
- 20.9×Sector 17.8×
- Promoter holding
- 69.69%-0.25% QoQ
- FII holding
- 0.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Antelopus Selan Energy Ltd
All →Antelopus Selan Energy Earnings Call Transcript: Key Takeaways
Management is banking on production ramp-up from Bakrol and Karjisan to reach 2,500 BOEPD exit rate, despite a flat QoQ volume performance and volatility in realized crude prices.
Antelopus Selan Energy Investor Presentation: Key Takeaways
Q2 FY27 net revenue ₹119.1 Cr (+116% YoY), EBITDA ₹90.0 Cr, PAT ₹57.3 Cr (+386% YoY). Average production 1,656 boepd; targets 2,500 boepd FY27 exit.
Antelopus Selan Energy Q2 FY27 Results: Net Profit ₹57.3 Cr, Up 385.6% YoY
Antelopus Selan Energy Ltd reported revenue from operations of ₹119.1 Cr (+116.2% YoY) and net profit of ₹57.3 Cr (+385.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹57.3 Cr · +385.6% YoY
Antelopus Selan Energy Board Meeting Date
Antelopus Selan Energy has scheduled its Board meeting for October 26, 2026 to approve Q1 and H1 FY27 unaudited results. The trading window stays closed until October 28, 2026.
Antelopus Selan Energy Employee Stock Options
Antelopus Selan Energy Limited allotted 51,530 equity shares upon the exercise of options under the Company's Employees Stock Option Scheme – 2022.
Antelopus Selan Energy Other Announcement
Antelopus Selan Energy Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. This is a periodic compliance disclosure.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date